Micah Anderson
Directeur Général chez LEEF BRANDS INC.
Fortune : 2 M $ au 31/05/2024
Profil
Micah Anderson is the founder of Leef Holdings, Inc. She is currently the Chief Executive Officer & Director at Leef Brands, Inc. and also holds the position of Chief Executive Officer & Director at Aya Biosciences, Inc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LEEF BRANDS INC
10,97% | 19/01/2024 | 127 808 454 ( 10,97% ) | 2 M $ | 31/05/2024 |
Postes actifs de Micah Anderson
| Sociétés | Poste | Début |
|---|---|---|
| LEEF BRANDS INC. | Directeur Général | 06/09/2022 |
Leef Holdings, Inc.
 Leef Holdings, Inc. Agricultural Commodities/MillingProcess Industries Leef Holdings, Inc. provides investment services. The company was founded in 2019 and is headquartered in La Jolla, CA. | Directeur Général | - |
Aya Biosciences, Inc.
 Aya Biosciences, Inc. BiotechnologyHealth Technology Aya Biosciences, Inc. is a neuroscience company that is dedicated to improving the mental health and well-being of patients with neuropsychiatric diseases. The company is based in La Jolla, CA. The company is creating a pipeline of novel, orally active serotonin receptor agonists as a new class of therapeutics. The CEO of the company is Micah Anderson. | Directeur Général | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LEEF BRANDS INC. | Process Industries |
| Entreprise privées | 2 |
|---|---|
Leef Holdings, Inc.
Leef Holdings, Inc. Agricultural Commodities/MillingProcess Industries Leef Holdings, Inc. provides investment services. The company was founded in 2019 and is headquartered in La Jolla, CA. | Process Industries |
Aya Biosciences, Inc.
Aya Biosciences, Inc. BiotechnologyHealth Technology Aya Biosciences, Inc. is a neuroscience company that is dedicated to improving the mental health and well-being of patients with neuropsychiatric diseases. The company is based in La Jolla, CA. The company is creating a pipeline of novel, orally active serotonin receptor agonists as a new class of therapeutics. The CEO of the company is Micah Anderson. | Health Technology |
